We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+5.28%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$17.8B
AUM Growth
+$1.26B
(+7.6%)
Cap. Flow
+$567M
Cap. Flow
% of AUM
3.2%
Top 10 Holdings %
Top 10 Hldgs %
11.28%
Holding
2,904
New
221
Increased
694
Reduced
820
Closed
148
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
McKesson
MCK
|
+$82.7M |
| 2 |
PepsiCo
PEP
|
+$76.8M |
| 3 |
Marriott International
MAR
|
+$64.8M |
| 4 |
Tyson Foods
TSN
|
+$62.8M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$64.8M |
| 2 |
Hormel Foods
HRL
|
+$61.4M |
| 3 |
Gilead Sciences
GILD
|
+$59.9M |
| 4 |
Hilton Worldwide
HLT
|
+$54.7M |
| 5 |
TechnipFMC
FTI
|
+$51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.87% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.71% |
| 4 | Industrials | 10.79% |
| 5 | Consumer Discretionary | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BNY
201
Bank of New York Mellon
BNY
$108B
| $29.6M | 0.17% |
741,245
-232,697
| -24% | -$9.29M |
|
202
Huntsman Corp
HUN
$2.24B
| $29.2M | 0.16% |
1,795,961
-165,218
| -8% | -$2.62M |
|
203
Euronet Worldwide
EEFT
$3.02B
| $29.2M | 0.16% |
356,765
-5,271
| -1% | -$404K |
|
|
UMPQ
204
DELISTED
Umpqua Holdings Corp
UMPQ
| $29.2M | 0.16% |
1,937,305
+2,333
| +0.1% | +$36.4K |
|
205
Eagle Bancorp
EGBN
$867M
| $29.1M | 0.16% |
590,205
+1,899
| +0.3% | +$95.3K |
|
206
Nasdaq
NDAQ
$52.1B
| $28.9M | 0.16% |
1,281,747
-153,258
| -11% | -$3.54M |
|
207
iShares MSCI USA Min Vol Factor ETF
USMV
$23.2B
| $28.8M | 0.16% |
633,997
+62,427
| +11% | +$2.89M |
|
|
SCHW
208
Charles Schwab
SCHW
$177B
| $28.8M | 0.16% |
911,868
+60,499
| +7% | +$1.77M |
|
|
K
209
DELISTED
Kellanova
K
| $28.8M | 0.16% |
395,635
-9,681
| -2% | -$741K |
|
|
CTXS
210
DELISTED
Citrix Systems Inc
CTXS
| $28.7M | 0.16% |
422,686
-41,333
| -9% | -$2.82M |
|
211
Manhattan Associates
MANH
$8.97B
| $28.6M | 0.16% |
497,257
+491,187
| +8,092% | +$29.6M |
|
212
Home BancShares
HOMB
$6.21B
| $28.5M | 0.16% |
1,371,689
+1,359,447
| +11,105% | +$29.2M |
|
|
FCB
213
DELISTED
FCB Financial Holdings, Inc.
FCB
| $28.5M | 0.16% |
742,724
+2,365
| +0.3% | +$87.2K |
|
|
CAA
214
DELISTED
CalAtlantic Group, Inc.
CAA
| $28.5M | 0.16% |
853,264
+80,256
| +10% | +$2.94M |
|
215
Snap-on
SNA
$20.9B
| $28.3M | 0.16% |
186,555
+181,583
| +3,652% | +$28.1M |
|
216
LyondellBasell Industries
LYB
$19.5B
| $28.3M | 0.16% |
350,691
-588,801
| -63% | -$45.5M |
|
217
Matsons
MATX
$6.37B
| $28.1M | 0.16% |
704,796
+649,988
| +1,186% | +$24.1M |
|
218
Cirrus Logic
CRUS
$6.74B
| $28M | 0.16% |
526,406
-460,895
| -47% | -$22.2M |
|
219
Medtronic
MDT
$107B
| $27.9M | 0.16% |
323,309
-16,601
| -5% | -$1.45M |
|
|
SRCI
220
DELISTED
SRC Energy Inc
SRCI
| $27.9M | 0.16% |
+4,024,918
| New | +$26.6M |
|
221
CSX Corp
CSX
$98.6B
| $27.6M | 0.16% |
2,712,021
+2,316,405
| +586% | +$21.9M |
|
222
United Therapeutics
UTHR
$26.3B
| $27.5M | 0.16% |
233,270
+23,053
| +11% | +$2.77M |
|
223
Northern Trust
NTRS
$22.2B
| $27.5M | 0.16% |
404,950
+4,632
| +1% | +$315K |
|
|
TMH
224
DELISTED
Team Health Holdings Inc
TMH
| $27.5M | 0.16% |
845,400
+2,255
| +0.3% | +$83.2K |
|
225
Amdocs
DOX
$5.53B
| $27.5M | 0.16% |
475,604
-41,860
| -8% | -$2.47M |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2016 Portfolio in Review
As of Q3 2016, Glenmede Trust held 2,904 positions worth $17.8B, up 7.6% from $16.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Glenmede Trust deployed $567M of net new capital in Q3 2016, opening 221 new positions and adding to 694 existing holdings. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Starbucks, an estimated $64.8M trimmed.
- Glenmede Trust's largest Q3 2016 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 2,050,199 shares worth $37.2M.
- Glenmede Trust added most to McKesson in Q3 2016, an estimated $82.7M increase.
- Glenmede Trust's biggest Q3 2016 reduction was Starbucks, cutting an estimated $64.8M.
- Glenmede Trust fully exited WILSHIRE BANCORP INC in Q3 2016, selling an estimated $18.5M.
- Glenmede Trust's ten largest holdings make up 11% of its $17.8B portfolio in Q3 2016.
- Glenmede Trust opened 221 new positions and closed 148 in Q3 2016.
- Glenmede Trust's portfolio value rose 7.6% quarter-over-quarter to $17.8B.
Based on Glenmede Trust's 13F filing for Q3 2016, filed 14 Nov 2016.